Cutaneous manifestations of diabetes mellitus: a clinical study

Authors

  • Nancy Bhardwaj Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
  • Samarjit Roy Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
  • Rashmi Jindal Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
  • Sohaib Ahmad Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20183157

Keywords:

Cutaneous, Diabetes mellitus, Uttarakhand

Abstract

Background: Diabetes mellitus is a leading cause of morbidity with adverse effects on various systems including skin. Cutaneous manifestations seen in diabetes aid in its diagnosis and some of them may also correlate with diabetic control, duration and other complications. This study was undertaken to estimate burden of skin disorders among diabetics in a tertiary care centre of Uttarakhand.

Methods: The study was conducted at Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India, over a period of one year from January 2016 to December 2016. Three hundred and seventy seven patients irrespective of age and sex were included in the study and those with gestational diabetes were excluded. Patients were examined for mucocutaneous manifestations and evaluated. Structured case reporting form was used to generate data.

Results: Out of 377 patients studies, 114 (30.2%) were in the age group of 51-60 years. Male to female ratio was 1.44:1. Mucocutaneous manifestations were present in 278/377 (73.7%) patients. Common cutaneous manifestations were cutaneous infections [fungal infections (n=106/377; 28.1%), bacterial infections (n=33/377; 8.8%)], pruritus (n=47/377; 12.5%), xerosis (n=39/377; 10.3%), diabetic dermopathy (n=36/377; 9.5%) and diabetic ulcers (n=24/377; 6.4%). Uncommon manifestations were necrobiosis lipoidica diabeticorum, alopecia areata, scleredema diabeticorum and granuloma annulare. Cutaneous reactions due to treatment of diabetes were noted in 4 (1%) patients.

Conclusions: As prevalence of cutaneous manifestations is high in diabetic patients, knowledge of these will help in a timely and comprehensive management of both diabetes and dermatoses.

References

Kalus AA, Chien AJ, Olerud JE. Diabetes mellitus and other endocrine diseases. In: Wolff K, Goldsmith LA, Katz SI, editors. Fitz Patrick’s Dermatology in general medicine. 7th ed. New York: McGraw Hill; 2006: 1461-1507.

Nigam PK, Pande S. Pattern of dermatoses in diabetics. Indian J Dermatol Venereol Leprol. 2003;69:83–5.

Blakytny R, Jude EB. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds 2009;8:95–104.

Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012;26:1203–11.

Timshina DK, Thappa DM, Agrawal A. A Clinical Study of Dermatoses in Diabetes to Establish its Markers. Indian J of Dermatol. 2012;57:20-5.

Mahajan S, Koranne R, Sharma S. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol. 2003;69:105–8.

Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care Hospital of Eastern India. Indian J Endocrinol Metab. 2014;18:217-20.

Sanad EM, ElFangary MM, Sorour NE, ElNemisy NM. Skin manifestations in Egyptian diabetic patients: a case series study. Egypt J Dermatol Venerol. 2013;33:56–62.

Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat. Indian J Endocrinol Metab. 2013;17:659-64.

Goyal A, Raina S, Kaushal SS, Mahajan V, Sharma NL. Pattern of cutaneous manifestation in diabetes mellitus. Indian J Dermatol. 2010;55:39–41.

Ragunatha S, Anitha B, Inamadar AC, Palit A, Devarmani SS. Cutaneous disorders in 500 diabetic patients attending diabetic clinic. Indian J Dermatol. 2011;56:160-4.

Niaz F, Bashir F, Shams N, Shaikh Z, Ahmed I. Cutaneous manifestations of diabetes mellitus type 2: prevalence and association with glycemic control. J Pak Assoc Dermatol. 2016;26:4-11.

Shahzad M, Al Robaee A, Al Shobaili HA, Al Marshood AA. Skin manifestations in diabetic patients attending a diabetic clinic in the Qassim region, Saudi Arabia. Med Princ Pract. 2011;20:137-41.

Hosseini MS, Ehsani AH, Panah FH, Azizi F. The Correlation between Skin Lesions, Microalbuminuria and other Microvascular Complications in Type 2 Diabetic Patients. Int J Nephrol Urol. 2010;2:553-60.

Romano G, Morretti G, Di benedetto A. Skin lesions in diabetes mellitus: Prevalence and clinical correlations. Diabetes Res Clin Pract. 1990;39:101-6.

Bala K, Chander J, Handa U, Punia RS and Attri AK. A prospective study of mucormycosis in north India: Experience from a tertiary care hospital. Medical Mycology. 2015;53:248–57.

Raghu TY, Vinayak V, Kanthraj GR, Girisha BS. Study of cutaneous manifestations of diabetes mellitus. Indian J Dermatol. 2004;49:73-5.

Downloads

Published

2018-07-24

Issue

Section

Original Research Articles